The aim of this study is to evaluate the efficacy of cervical cerclage in prevention of spontaneous preterm birth in singleton pregnancies with a short transvaginal cervical length (\<=25mm) and without prior spontaneous preterm birth
Singleton pregnancies between 18 0/7 to 23 6/7 weeks without a prior spontaneous preterm birth found to have a short transvaginal ultrasound cervical length (\<=25mm) and meeting all other eligibility criteria will be randomized to either cervical cerclage or control (no cerclage). Aside from cerclage placement, management of included women will be the same including recommendation for daily vaginal progesterone 200mg suppository or 90mg gel from randomization until 36 6/7 weeks. The primary outcome will be the incidence of spontaneous preterm birth \<35 weeks
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
93
Transvaginal cervical cerclage placed between 18 0/7 - 23 6/7 weeks
Vaginal progesterone 200mg suppository or 90mg gel nightly from randomization until 36 weeks
Thomas Jefferson University Hospital
Philadelphia, Pennsylvania, United States
University of Naples Federico II
Naples, Italy
University Cattolica del S. Cuore
Rome, Italy
Preterm birth <35 weeks
Incidence of spontaneous preterm birth less than 35 weeks
Time frame: At delivery
Preterm birth <37 weeks, <34 weeks, <32 weeks, <28 weeks, <24 weeks
Time frame: At delivery
Mean gestational age at delivery
Time frame: At delivery
Histologically proven clinical chorioamnionitis
Time frame: At delivery
Neonatal outcomes: birth weight
Time frame: At delivery
Neonatal outcomes: low birth weight (<2500g),
Time frame: At delivery
Neonatal outcomes: admission to intensive care nursery
Time frame: At delivery
Neonatal outcomes: length of neonatal hospital admission
Time frame: at least 30 days after delivery, up to 6 months after delivery
Neonatal outcomes: respiratory distress syndrome
Time frame: at least 30 days after delivery, up to 6 months after delivery
Neonatal outcomes: IVH grade 3 or 4
Time frame: at least 30 days after delivery, up to 6 months after delivery
Neonatal outcomes: retinopathy of prematurity
Time frame: at least 30 days after delivery, up to 6 months after delivery
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Neonatal outcomes: bronchopulmonary dysplasia
Time frame: at least 30 days after delivery, up to 6 months after delivery
Neonatal outcomes: neonatal mortality
Time frame: 28 days after delivery